Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Bogunovic, Branka ^a   Srinivasan, Priya ^a   Ueda, Yumi ^b   Tomita, York ^b   Maric, Maja ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CD4 ANTIGEN; CYCLIN B1; DISULFIDE; EPITOPE; GAMMA INTERFERON INDUCIBLE LYSOSOMAL THIOL REDUCTASE; HELICASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; OXIDOREDUCTASE; PROLINE RICH PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISULFIDE BOND; ELECTROSPRAY MASS SPECTROMETRY; ENDOCYTOSIS; IMMUNE RESPONSE; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES; PEPTIDES; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPLEEN;

EID: 77956518732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010599     Document Type: Article

References (40)

1. Goldrath AW, Bevan MJ (1999) Selecting and maintaining a diverse T-cell repertoire. Nature 402: 255-262.
2. Marleau AM, Sarvetnick N (2005) T cell homeostasis in tolerance and immunity. J Leukoc Biol 78: 575-584.
3. Vukmanovic S, Santori FR (2005) Self-peptide/MHC and TCR antagonism: physiological role and therapeutic potential. Cell Immunol 233: 75-84.
4. Maric M, Arunachalam B, Phan UT, Dong C, Garrett WS, et al. (2001) Defective antigen processing in GILT-free mice. Science 294: 1361-1365.
5. Shilov IV, seymour SL, Patel AA, loboda A, et al. (2007) The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6: 1638-1655.
6. Surman S, Lockey TD, Slobod KS, Jones B, Riberdy JM, et al. (2001) Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc Natl Acad Sci U S A 98: 4587-4592.
7. Thiede B, Lamer S, Mattow J, Siejak F, Dimmler C, et al. (2000) Analysis of missed cleavage sites, tryptophan oxidation and N-terminal pyroglutamylation after in-gel tryptic digestion. Rapid Commun Mass Spectrom 14: 496-502.
8. Morand K, Talbo G, Mann M (1993) Oxidation of peptides during electrospray ionization. Rapid Commun Mass Spectrom 7: 738-743.
9. Reche PA, Glutting JPa, EL. R (2002) Prediction of MHC Class I Binding Peptides Using Profile Motifs. Human Immunology 63: 701-709.
10. Rudensky A, Rath S, Preston-Hurlburt P, Murphy DB, Janeway CA, Jr. (1991) On the complexity of self. Nature 353: 660-662.
11. Janeway CA, Jr., Conrad PJ, Lerner EA, Babich J, Wettstein P, et al. (1984) Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J Immunol 132: 662-667.
12. Santori FR, Kieper WC, Brown SM, Lu Y, Neubert TA, et al. (2002) Rare, structurally homologous self-peptides promote thymocyte positive selection. Immunity 17: 131-142.
13. Sinnathamby G, Maric M, Cresswell P, Eisenlohr LC (2004) Differential requirements for endosomal reduction in the presentation of two H2-E(d)- restricted epitopes from influenza hemagglutinin. J Immunol 172: 6607-6614.
14. Sealy R, Chaka W, Surman S, Brown SA, Cresswell P, et al. (2008) Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities. Clin Vaccine Immunol 15: 713-719.
15. Haque MA, Li P, Jackson SK, Zarour HM, Hawes JW, et al. (2002) Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J Exp Med 195: 1267-1277.
16. Li P, Haque MA, Blum JS (2002) Role of disulfide bonds in regulating antigen processing and epitope selection. J Immunol 169: 2444-2450.
17. Maric M, Barjaktarevic I, Bogunovic B, Stojakovic M, Maric C, et al. (2009) Cutting edge: developmental up-regulation of IFN-gamma-inducible lysosomal thiol reductase expression leads to reduced T cell sensitivity and less severe autoimmunity. J Immunol 182: 746-750.
18. Bogunovic B, Stojakovic M, Chen L, Maric M (2008) An unexpected functional link between lysosomal thiol reductase and mitochondrial manganese superoxide dismutase. J Biol Chem 283: 8855-8862.
19. Kiffin R, Bandyopadhyay U, Cuervo AM (2006) Oxidative stress and autophagy. Antioxid Redox Signal 8: 152-162.
20. Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB (2008) Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ 15: 171-182.
21. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C (1995) Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3: 783-791.
22. Reis e Sousa C, Germain RN (1995) Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 182: 841-851.
23. Kovacsovics-Bankowski M, Rock KL (1995) A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267: 243-246.
24. Dongre AR, Kovats S, deRoos P, McCormack AL, Nakagawa T, et al. (2001) In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur J Immunol 31: 1485-1494.
25. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, et al. (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255: 1261-1263.
26. Doyle HA, Mamula MJ (2001) Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 22: 443-449.
27. Wucherpfennig KW (2001) Insights into autoimmunity gained from structural analysis of MHC-peptide complexes. Curr Opin Immunol 13: 650-656.
28. Chen W, Yewdell JW, Levine RL, Bennink JR (1999) Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants. J Exp Med 189: 1757-1764.
29. Zamvil SS, Mitchell DJ, Moore AC, Kitamura K, Steinman L, et al. (1986) Tcell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324: 258-260.
30. van Stipdonk MJ, Willems AA, Amor S, Persoon-Deen C, Travers PJ, et al. (1998) T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen. Int Immunol 10: 943-950.
31. Utz PJ, Hottelet M, Schur PH, Anderson P (1997) Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 185: 843-854.
32. Neugebauer KM, Merrill JT, Wener MH, Lahita RG, Roth MB (2000) SR proteins are autoantigens in patients with systemic lupus erythematosus. Importance of phosphoepitopes. Arthritis Rheum 43: 1768-1778.
33. Arentz-Hansen H, Korner R, Molberg O, Quarsten H, Vader W, et al. (2000) The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191: 603-612.
34. Sollid LM (2000) Molecular basis of celiac disease. Annu Rev Immunol 18: 53-81.
35. Skipper JC, Hendrickson RC, Gulden PH, Brichard V, Van Pel A, et al. (1996) An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 183: 527-534.
36. Kittlesen DJ, Thompson LW, Gulden PH, Skipper JC, Colella TA, et al. (1998) Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. J Immunol 160: 2099-2106.
37. Zarling AL, Ficarro SB, White FM, Shabanowitz J, Hunt DF, et al. (2000) Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J Exp Med 192: 1755-1762.
38. Chervonsky AV, Medzhitov RM, Denzin LK, Barlow AK, Rudensky AY, et al. (1998) Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides. Proc Natl Acad Sci U S A 95: 10094-10099.
39. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA, Jr. (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353: 622-627.
40. Eastman S, Deftos M, DeRoos PC, Hsu DH, Teyton L, et al. (1996) A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody. Eur J Immunol 26: 385-393.